[{"Assets_0_Q2_USD":529139000.0,"CommonStockSharesOutstanding_0_Q2_shares":36752000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-53046000.0,"NetIncomeLoss_1_Q2_USD":-1457000.0,"NetIncomeLoss_2_Q2_USD":-33685000.0,"StockholdersEquity_0_Q2_USD":494592000.0,"EarningsPerShareBasic_1_Q2_USD":-0.04,"EarningsPerShareBasic_2_Q2_USD":-0.92,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":36669000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":36518000.0,"Ticker":"RGNX","CIK":"1590877","name":"REGENXBIO INC.","OfficialName":"REGENXBIO Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1299022052.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]